Log in
Enquire now
‌

Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT02327546
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT023275460
Trial Recruitment Size
100
Trial Sponsor
Akebia Therapeutics
Akebia Therapeutics
0
Clinical Trial Start Date
2014
0
Primary Completion Date
2014
0
Study Completion Date
2015
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Other0
Intervention Type
Drug0
Intervention Name
Ferrous Sulfate0
AKB-65480
Interventional Trial Phase
Phase 10
Official Name
An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers0
Last Updated
November 14, 2018
0
Allocation Type
Randomized0
Intervention Model
Crossover Assignment0
Masking Type
None (Open Label)0
Study summary

The primary purpose of this study is to assess the single-dose bioavailability of AKB-6548 with ferrous sulfate relative to AKB-6548 in healthy volunteers.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.